Pfizer announced that it has completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals through a merger of Pfizer’s wholly owned subsidiary, Explorer Acquisition Corp.
Company news
Pfizer announced that it has completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals through a merger of Pfizer's wholly-owned subsidiary, Explorer Acquisition Corp.